ChartMill assigns a Buy % Consensus number of 78% to OPT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-25 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-03-25 | Jefferies | Downgrade | Buy -> Underperform |
| 2025-03-25 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Initiate | Buy |
| 2023-03-13 | Oppenheimer | Maintains | Outperform |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-16 | Citigroup | Maintains | Buy |
| 2022-04-26 | SVB Leerink | Initiate | Outperform |
10 analysts have analysed OPT and the average price target is 6.57 USD. This implies a price increase of 92.75% is expected in the next year compared to the current price of 3.41.
The consensus rating for OPTHEA LTD-SPON ADR (OPT) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.